Provided by Tiger Trade Technology Pte. Ltd.

VanEck Healthcare TruSector ETF

29.23
+0.00770.03%
Post-market: 29.260.0281+0.10%16:04 EDT
Volume:363
Turnover:10.62K
Market Cap:584.60K
PE:- -
High:29.24
Open:29.24
Low:29.23
Close:29.22
52wk High:30.68
52wk Low:24.78
Shares:20.00K
Float Shares:20.00K
Volume Ratio:0.33
T/O Rate:1.82%
Dividend:0.08
Dividend Rate:0.29%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly Completes Acquisition of AtaiBeckley

Reuters
·
Sep 11

Lilly Completes Acquisition of Ataibeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions

THOMSON REUTERS
·
Sep 11

Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)

TIPRANKS
·
Sep 11

Berenberg Lifts Price Target on Merck to $137 From $127, Keeps Hold Rating

MT Newswires Live
·
Sep 11

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

TIPRANKS
·
Sep 11

MS Cuts Novo Nordisk on Growth Prospects, Patent Expiry Risks

Reuters
·
Sep 11

Growth Without AI: 8 Stock Picks

Dow Jones
·
Sep 11

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 11

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Reuters
·
Sep 11

AbbVie Declares Quarterly Cash Dividend of $1.73 a Share

Reuters
·
Sep 11

Abbvie - Declares Qtrly Cash Dividend of $1.73 Per Share

THOMSON REUTERS
·
Sep 11

AbbVie’s Eye Implant Study Delivers Fresh Real‑World Clarity for Investors

TIPRANKS
·
Sep 11

Wachtell Dealmaker Jumps to Linklaters to Bolster US Buildout

Reuters
·
Sep 10

Johnson & Johnson Announces R$ 0.3 Per Unit Dividend for 3Q 2026

Reuters
·
Sep 10

Eli Lilly is Maintained at Reduce by HSBC

Dow Jones
·
Sep 10

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

Reuters
·
Sep 10

AbbVie Says Atogepant Met Primary, Secondary Endpoints in Phase 3 Menstrual Migraine Study

MT Newswires Live
·
Sep 10

AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine

TIPRANKS
·
Sep 10

Abbvie - Atogepant Safety Results Consistent with Known Profile; no New Safety Signals

THOMSON REUTERS
·
Sep 10